These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 4205945)

  • 21. Characterization of an enterotoxin produced by Vibrio cholerae O139.
    Nakashima K; Eguchi Y; Nakasone N
    Microbiol Immunol; 1995; 39(2):87-94. PubMed ID: 7783690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purification of enterotoxins from Vibrio mimicus that appear to be identical to cholera toxin.
    Spira WM; Fedorka-Cray PJ
    Infect Immun; 1984 Sep; 45(3):679-84. PubMed ID: 6469354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The study of intestinal immunity against V. cholerae: purification of V. cholerae El Tor haemagglutinin and the protective role of its antibody in experimental cholera.
    Chaicumpa W; Atthasishtha N
    Southeast Asian J Trop Med Public Health; 1979 Mar; 10(1):73-80. PubMed ID: 483020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Systemic immunity of experimental animals immunized with cholera vaccines].
    Genova IuG; Bogatinov VT; Manakhilov RB; Kostova EF
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Nov; (11):41-4. PubMed ID: 3434048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenesis of experimental cholera. Preparation and isolation of choleragen and choleragenoid.
    Finkelstein RA; LoSpalluto JJ
    J Exp Med; 1969 Jul; 130(1):185-202. PubMed ID: 4978880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The application of QAE-Sephadex for the purification of two staphylococcal enterotoxins. I. Purification of enterotoxin C2.
    Robern H; Stavric S; Dickie N
    Biochim Biophys Acta; 1975 May; 393(1):148-58. PubMed ID: 237564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrinsic and chemically produced microheterogeneity of Staphylococcus aureus enterotoxin type C.
    Metzger JF; Johnson AD; Spero L
    Infect Immun; 1975 Jul; 12(1):93-7. PubMed ID: 237837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coagglutination test for rapid detection of Salmonella enterotoxin.
    Rahman H; Singh VB; Sharma VD; Harne SD
    Zentralbl Bakteriol; 1991 Aug; 275(3):303-11. PubMed ID: 1741910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dissociation and recombination of the subunits of the cholera enterotoxin (choleragen).
    Finkelstein RA; Boesman M; Neoh SH; LaRue MK; Delaney R
    J Immunol; 1974 Jul; 113(1):145-50. PubMed ID: 4208916
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of erythrocytes sensitized with purified enterotoxin from Vibrio cholerae for the assay of antibody and antibody-forming cells.
    Kateley JR; Friedman H
    J Infect Dis; 1975 Feb; 131(2):144-8. PubMed ID: 1090686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crystalline cholera toxin and toxoid.
    Finkelstein RA; LoSpalluto JJ
    Science; 1972 Feb; 175(4021):529-30. PubMed ID: 5008591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bovine lactogenic immunity against cholera toxin-related enterotoxins and Vibrio cholerae outer membranes.
    Boesman-Finkelstein M; Walton NE; Finkelstein RA
    Infect Immun; 1989 Apr; 57(4):1227-34. PubMed ID: 2925248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation of a purified antigenic cholera toxoid.
    Germanier R; Fürer E; Varallyay S; Inderbitzin TM
    Infect Immun; 1976 Jun; 13(6):1692-8. PubMed ID: 823107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oligomeric structure of cholera toxin: characteristics of the H and L subunits.
    Holmgren J; Lonnroth I
    J Gen Microbiol; 1975 Jan; 86(1):49-65. PubMed ID: 803547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental immunisation and protection of guinea pigs with Vibrio cholerae toxoid and mucinases, neuraminidase and proteinase.
    Stewart-Tull DE; Lucas C; Bleakley CR
    Vaccine; 2004 Jun; 22(17-18):2137-45. PubMed ID: 15149770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Vibrio eltor strain, serotype Ogawa, the producer of cholera enterotoxin].
    Saiamov RM; Avrorov VP; Khanum'ian TA
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Mar; (3):40-2. PubMed ID: 6342310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Strains of Vibrio cholerae serogroups O1 and O139 that produce the basic protective antigens].
    Smirnova NI; Livanova LF; Chekhovskaia GV; Eroshenko GA; Lazovskiĭ IuV; Zakharova TL
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (3):47-51. PubMed ID: 10925874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform.
    Liao J; Gibson JA; Pickering BS; Watnick PI
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29875145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the Chinese hamster ovary cell assay for the enterotoxins of Vibrio cholerae and Escherichia coli and for specific antisera, and toxoid.
    Guerrant RL; Brunton LL
    J Infect Dis; 1977 May; 135(5):720-8. PubMed ID: 323378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Escherichia coli heat-stable enterotoxin: rapid method of purification and some characteristics of the toxin.
    Lallier R; Lariviere S; St-Pierre S
    Infect Immun; 1980 May; 28(2):469-74. PubMed ID: 6995310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.